HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kara A Lombardo Selected Research
Kara A Lombardo Research Topics
Disease
11
Neoplasms (Cancer)
05/2024 - 01/2016
8
Carcinoma (Carcinomatosis)
01/2024 - 01/2018
4
Urinary Bladder Neoplasms (Bladder Cancer)
05/2024 - 01/2022
3
Bites and Stings (Sting)
12/2023 - 01/2022
2
Virus Diseases (Viral Diseases)
10/2023 - 03/2022
2
Carcinoma in Situ
01/2021 - 01/2019
2
Small Cell Carcinoma
01/2021 - 02/2020
2
Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2017
2
Adenocarcinoma
07/2018 - 01/2017
2
Eosinophilic Esophagitis
01/2018 - 10/2017
1
Pneumonia (Pneumonitis)
03/2022
1
COVID-19
03/2022
1
Non-Muscle Invasive Bladder Neoplasms
01/2022
1
Adenoid Cystic Carcinoma (Cylindroma)
01/2021
1
Sarcoma (Soft Tissue Sarcoma)
10/2018
1
Atrophy
01/2018
1
Hyperplasia
01/2018
1
Gender Dysphoria
01/2018
1
Myositis (Idiopathic Inflammatory Myopathies)
10/2017
1
Inflammation (Inflammations)
10/2017
1
Mitochondrial Myopathies (Mitochondrial Myopathy)
10/2017
1
Ulcer
01/2017
1
Genetic Translocation (Chromosomal Translocation)
01/2016
1
Neoplasm Metastasis (Metastasis)
01/2016
1
Adenocarcinoma of Lung
01/2016
1
Colorectal Neoplasms (Colorectal Cancer)
01/2016
Drug/Important Bio-Agent (IBA)
4
RNA (Ribonucleic Acid)
IBA
03/2022 - 10/2017
2
cyclic diadenosine phosphate
IBA
12/2023 - 01/2022
2
Pathogen-Associated Molecular Pattern Molecules
IBA
12/2023 - 01/2022
2
Vaccines
IBA
10/2023 - 03/2022
2
Proteins (Proteins, Gene)
FDA Link
01/2022 - 01/2021
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2018
2
Interferons
IBA
01/2022 - 01/2022
2
Succinate Dehydrogenase (Fumarate Reductase)
IBA
01/2021 - 10/2017
1
JHU083
IBA
05/2024
1
Prodrugs
IBA
05/2024
1
Glutamine (L-Glutamine)
FDA Link
05/2024
1
Carcinogens
IBA
01/2022
1
enfortumab vedotin
IBA
01/2021
1
Messenger RNA (mRNA)
IBA
01/2021
1
Fumarate Hydratase (Fumarase)
IBA
01/2021
1
trastuzumab deruxtecan
IBA
01/2021
1
Immunoconjugates (Immunoconjugate)
IBA
01/2021
1
Adenosine Monophosphate (AMP)
IBA
02/2020
1
prostein
IBA
01/2020
1
Photosensitizing Agents (Photosensitizers)
IBA
01/2019
1
Coloring Agents (Dyes)
IBA
10/2018
1
HLA-A Antigens (HLA-A)
IBA
10/2018
1
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
07/2018
1
Mucin-1 (CA 15-3 Antigen)
IBA
01/2018
1
Chemotactic Factors
IBA
01/2018
1
Cadherins (E-Cadherin)
IBA
01/2018
1
Immunoglobulin G (IgG)
IBA
01/2017
1
Prostate-Specific Antigen (Semenogelase)
IBA
01/2017
1
Anaplastic Lymphoma Kinase
IBA
01/2016
1
ceritinib
IBA
01/2016
Therapy/Procedure
5
Therapeutics
01/2022 - 10/2017
2
Neoadjuvant Therapy
01/2024 - 01/2017
1
Drug Therapy (Chemotherapy)
01/2024
1
Radiotherapy
01/2022
1
Transurethral Resection of Bladder
02/2020
1
Cystectomy
02/2020
1
Sex Reassignment Surgery
01/2018
1
Transurethral Resection of Prostate (TURP)
01/2018
1
Cautery
01/2018
1
Chemoradiotherapy
01/2017
1
Cytoreduction Surgical Procedures
01/2017